Pediatric donor (PD) livers have been allocated to adult transplant recipie
nts in certain situations despite size discrepancies. We compared data on a
dults (age greater than or equal to 19 years) who underwent primary liver t
ransplantation using livers from either PDs (age < 13 years; n = 70) or adu
lt donors (ADs; age <greater than or equal to> 19 years; n = 1,051). We als
o investigated the risk factors and effect of prolonged cholestasis on surv
ival in the PD group. In an attempt to determine the minimal graft volume r
equirement, we divided the PD group into 2 subgroups based on the ratio of
donor liver weight (DLW) to estimated recipient liver weight (ERLW) at 2 di
fferent cutoff values: less than 0.4 (n = 5) versus 0.4 or greater (n 56) a
nd less than 0.5 (n = 21) versus 0.5 or greater (n = 40). The incidence of
hepatic artery thrombosis (HAT) was significantly greater in the PD group (
12.9%) compared with the AD group (3.8%; P =.0003). Multivariate analysis s
howed that preoperative prothrombin time of 16 seconds or greater (relative
risk 3.206; P =.0115) and absence of FK506 use as a primary immunosuppress
ant (relative risk, 4.477; P =.0078) were independent risk factors affectin
g 1-year graft survival in the PD group. In the PD group, transplant recipi
ents who developed cholestasis (total bilirubin level greater than or equal
to 5 mg/dL on postoperative day 7) had longer warm (WITs) and cold ischemi
c times (CITs). Transplant recipients with a DLW/ERLW less than 0.4 had a t
rend toward a greater incidence of HAT (40%; P <.06), septicemia (60%), and
decreased 1- and 5-year graft survival rates (40% and 20%; P =.08 and .07
v DLW/ERLW of 0.4 or greater, respectively), In conclusion, the use of PD l
ivers for adult recipients was associated with a greater risk for developin
g HAT. The outcome of small-for-size grafts is more likely to be adversely
affected by longer WITs and CITs. The safe limit of graft volume appeared t
o be a DLW/ERLW of 0.4 or greater.